Li P, Liu W, Zhou L, Ye S, et al. C-CAR066, a novel fully human anti-CD20 CAR-T therapy for relapsed or refractory large B-cell lymphoma after failure of anti-CD19 CAR-T therapy: A phase I clinical study. Am J Hematol 2024 Oct 1. doi: 10.1002/ajh.27488.
PMID: 39351902